*By Jacqueline Corba*
BODY: Shares of DocuSign surged 37 percent in the their market debut Friday. The electronic signature company raised $629 million in its initial public offering and ended the day with a market value of nearly $6 billion.
"The reception we've received on Wall Street has been great," said the DocuSign CEO Dan Springer. "The company has the scale, we have over 500 million dollars of revenue. The company continues to have great growth."
In fiscal 2018, DocuSign became cash-flow positive and generated $518 million in revenue.
Springer said the company is looking toward international expansion. Only 17 percent of the firm's revenue is from outside of the U.S.
For the full interview, [click here](https://cheddar.com/videos/docusign-ceo-dan-springer-on-first-day-of-trading).
Merriam-Webster has fully revised its popular “Collegiate” dictionary with over 5,000 new words. They include “petrichor,” “dumbphone” and “ghost kitchen.” Also “cold brew,” “rizz,” “dad bod,” “hard pass,” “cancel culture” and more.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
